Karyopharm Therapeutics Inc. (KPTI)

Karyopharm Therapeutics Market Cap

Karyopharm Therapeutics has a market cap or net worth of $115.89 million as of June 18, 2024. Its market cap has decreased by -54.01% in one year.

• Market Cap: 115.89M
• Enterprise Value: 143.03M
• 1-Year Change: -54.01%
• Ranking: #3929
• Category: Micro-Cap
• Stock Price: $0.93

Market Cap Chart

Since November 6, 2013, Karyopharm Therapeutics's market cap has decreased from $442.90M to $115.89M, a decrease of -73.83%. That is a compound annual growth rate of -11.86%.

Market Cap History

Date	Market Cap	% Change
Jun 17, 2024	114.50M	1.69%
Jun 14, 2024	112.60M	-6.24%
Jun 13, 2024	120.10M	-0.91%
Jun 12, 2024	121.20M	1.93%
Jun 11, 2024	118.90M	4.48%
Jun 10, 2024	113.80M	0.71%
Jun 7, 2024	113.00M	-1.31%
Jun 6, 2024	114.50M	-2.14%
Jun 5, 2024	117.00M	7.24%
Jun 4, 2024	109.10M	-6.19%
Jun 3, 2024	116.30M	1.93%
May 31, 2024	114.10M	2.24%
May 30, 2024	111.60M	-1.41%
May 29, 2024	113.20M	-3.25%
May 28, 2024	117.00M	-5.34%
May 24, 2024	123.60M	-3.66%
May 23, 2024	128.30M	-1.84%
May 22, 2024	130.70M	-0.83%
May 21, 2024	131.80M	-1.79%
May 20, 2024	134.20M	-0.89%
May 17, 2024	135.40M	1.35%
May 16, 2024	133.60M	0.45%
May 15, 2024	133.00M	3.66%
May 14, 2024	128.30M	-2.66%
May 13, 2024	131.80M	2.73%

View and export this data all the way back to 2013. Sign Up Today.

Related Stocks

Company	Market Cap
Harvard Bioscience	125.95M
Conduit Pharmaceuticals	125.44M
Electromed	125.42M
Corvus Pharmaceuticals	121.35M
aTyr Pharma	120.77M
Veru Inc.	119.05M
American Well	117.76M
Journey Medical	117.48M